Next Article in Journal
Mutation of a Conserved Nuclear Export Sequence in Chikungunya Virus Capsid Protein Disrupts Host Cell Nuclear Import
Next Article in Special Issue
A Bioinformatic Pipeline for Monitoring of the Mutational Stability of Viral Drug Targets with Deep-Sequencing Technology
Previous Article in Journal
Hepatitis B Virus and DNA Damage Response: Interactions and Consequences for the Infection
Previous Article in Special Issue
Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4+ T Cells
Open AccessReview

The Th17 Lineage: From Barrier Surfaces Homeostasis to Autoimmunity, Cancer, and HIV-1 Pathogenesis

1
Département of Microbiologie, Infectiologie et Immunologie and Centre de Recherche du CHUM, Faculté de Médecine, Université de Montréal, Montréal, QC H2X 0A9, Canada
2
Department of Immunology and Microbiology, Rush University Medical Center, Chicago, IL 60612, USA
3
Chronic Viral Illness Service and Division of Hematology, McGill University Health Centre, Montréal, QC H4A 3J1, Canada
*
Author to whom correspondence should be addressed.
Viruses 2017, 9(10), 303; https://doi.org/10.3390/v9100303
Received: 22 September 2017 / Revised: 11 October 2017 / Accepted: 13 October 2017 / Published: 19 October 2017
(This article belongs to the Special Issue Homage to Mark Wainberg)
The T helper 17 (Th17) cells represent a subset of CD4+ T-cells with unique effector functions, developmental plasticity, and stem-cell features. Th17 cells bridge innate and adaptive immunity against fungal and bacterial infections at skin and mucosal barrier surfaces. Although Th17 cells have been extensively studied in the context of autoimmunity, their role in various other pathologies is underexplored and remains an area of open investigation. This review summarizes the history of Th17 cell discovery and the current knowledge relative to the beneficial role of Th17 cells in maintaining mucosal immunity homeostasis. We further discuss the concept of Th17 pathogenicity in the context of autoimmunity, cancer, and HIV infection, and we review the most recent discoveries on molecular mechanisms regulating HIV replication/persistence in pathogenic Th17 cells. Finally, we stress the need for novel fundamental research discovery-based Th17-specific therapeutic interventions to treat pathogenic conditions associated with Th17 abnormalities, including HIV infection. View Full-Text
Keywords: Th17 cells; CCR6; autoimmunity; cancer; HIV-1; gut; antiretroviral therapy Th17 cells; CCR6; autoimmunity; cancer; HIV-1; gut; antiretroviral therapy
Show Figures

Figure 1

MDPI and ACS Style

Wacleche, V.S.; Landay, A.; Routy, J.-P.; Ancuta, P. The Th17 Lineage: From Barrier Surfaces Homeostasis to Autoimmunity, Cancer, and HIV-1 Pathogenesis. Viruses 2017, 9, 303. https://doi.org/10.3390/v9100303

AMA Style

Wacleche VS, Landay A, Routy J-P, Ancuta P. The Th17 Lineage: From Barrier Surfaces Homeostasis to Autoimmunity, Cancer, and HIV-1 Pathogenesis. Viruses. 2017; 9(10):303. https://doi.org/10.3390/v9100303

Chicago/Turabian Style

Wacleche, Vanessa S.; Landay, Alan; Routy, Jean-Pierre; Ancuta, Petronela. 2017. "The Th17 Lineage: From Barrier Surfaces Homeostasis to Autoimmunity, Cancer, and HIV-1 Pathogenesis" Viruses 9, no. 10: 303. https://doi.org/10.3390/v9100303

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop